SCHEMBL7637124

SCHEMBL7637124

COc1ccccc1C(C)C(=O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.53
PTGS2 P35354 1/20 0.53
KMT2A Q03164 2/20 0.51
POLB P06746 2/20 0.50
HTT P42858 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA12 O43570 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
LPAR1 Q92633 1/20 0.44
HPGD P15428 2/20 0.44
ALDH1A1 P00352 1/20 0.44
ACHE P22303 1/20 0.44
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL362211 0.85 PTGS2 (0.64) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL8473051 0.85 PTGS2 (0.64) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL7885098 0.85 PTGS2 (0.64) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL27534818 0.82 KMT2A (0.52) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL15695551 0.81 PTGS1 (0.51) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL4807554 0.80 POLB (0.57) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL9729192 0.79 KMT2A (0.53) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL27602953 0.79 KMT2A (0.49) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL4554195 0.79 KMT2A (0.53) PTGS1PTGS2KMT2APOLBHTT
SCHEMBL5541713 0.79 LPAR1 (0.49) PTGS1PTGS2KMT2APOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111372936-B Mcl-1 selective inhibitors, their preparation and use 北京赛林泰医药技术有限公司 2022-12-02 CN disclosed
CN-111372936-A Mcl-1 selective inhibitors, their preparation and use 北京赛林泰医药技术有限公司 2020-07-03 CN disclosed
WO-2019101144-A1 SELECTIVE MCL-1 INHIBITOR AND PREPARATION AND USE THEREOF 北京赛林泰医药技术有限公司 2019-05-31 WO disclosed
US-6348617-B1 REACTING PYRUVIC ACID COMPOUND IN WATER WITH AMMONIUM OR ALKALI METAL BISULFITE TO GIVE AQUEOUS SOLUTION OF BISULFITE ADDUCT, ISOLATING BY PHASE SEPARATION, OPTIONALLY USING HYDROPHOBIC SOLVENT, CONTACTING WITH ACID TO DECOMPOSE ADDUCT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-02-19 US disclosed